A phase I study of SAR405838, a novel human double minute 2 (HDM2) antagonist, in patients with solid tumours

标题
A phase I study of SAR405838, a novel human double minute 2 (HDM2) antagonist, in patients with solid tumours
作者
关键词
De-differentiated liposarcoma, HDM2, MDM2, p53, Pharmacokinetics, Pharmacodynamics, SAR405838, Solid tumours
出版物
EUROPEAN JOURNAL OF CANCER
Volume 76, Issue -, Pages 144-151
出版商
Elsevier BV
发表日期
2017-03-17
DOI
10.1016/j.ejca.2017.02.005

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started